Wednesday, July 8, 2026

pharma · Renal Impairment · Urinary Tract Infection · SPRO

Spero Therapeutics

News and analysis for Spero Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

675 Massachusetts Ave, 14th Floor, Cambridge, MA 02139, US HQ
2013 Founded
45 Employees
Public company Type
SPRO · NYSE Ticker
Company details
Status
Public
HQ
675 Massachusetts Ave, 14th Floor, Cambridge, MA 02139, US
Founded
2013
Employees
45
Programs
21
Drugs
9
Patents
16
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Spero Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Spero Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Spero Therapeutics yet.

Back to company overview →